Story perspectives
Trump’s Tariffs on Drugs: U.S. Manufacturing vs. Quality Concerns
3/8/2025
44 8
1 of 1
Story summary
- President Trump is set to implement reciprocal tariffs on pharmaceuticals starting April 2, hoping to boost U.S. manufacturing. Yet, Indian drug executives remain skeptical, pointing to their low production costs. Amid ongoing concerns about drug quality, experts advocate for independent testing to ensure safety, rather than relying solely on tariffs.
